Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on Huntington's disease.

Sarah B Berman, J Timothy Greenamyre

    Current Neurology and Neuroscience Reports
    |July 11, 2006
    PubMed
    Summary
    This summary is machine-generated.

    Huntington's disease (HD) involves genetic mutations leading to neurodegeneration. This review covers HD's complex mechanisms and emerging targeted therapies for this progressive brain disorder.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Predicting the timing of first sustained cognitive worsening in Alzheimer's disease using real-world clinical data and machine learning.

    medRxiv : the preprint server for health sciences·2026
    Same author

    CNS-selective plasma p-tau217 accurately captures Alzheimer's disease pathology and progression.

    medRxiv : the preprint server for health sciences·2026
    Same author

    Olfaction, Cognition, and Early Signs of Neurodegenerative Disease in a Community-Based Sample of Older Adults.

    Alzheimer disease and associated disorders·2026
    Same author

    15 years of longitudinal genetic, clinical, cognitive, imaging, and biochemical measures in DIAN.

    NPJ dementia·2026
    Same author

    Anti-CD320 Autoantibodies and Central Nervous System Vitamin B12 Deficiency in Idiopathic Myelopathy.

    medRxiv : the preprint server for health sciences·2026
    Same author

    Biomarkers.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
    Same journal

    The Noradrenergic Brain in Parkinson's Disease.

    Current neurology and neuroscience reports·2026
    Same journal

    Mapping the Silent Onset of Parkinson's Disease: Monoamine Imaging in the Era of the Race for Preclinical Intervention.

    Current neurology and neuroscience reports·2026
    Same journal

    Functional and Structural Brain Imaging Correlates of Treatment Response in Functional Movement Disorder.

    Current neurology and neuroscience reports·2026
    Same journal

    Astrocytopathy in Wernicke Encephalopathy and Neuromyelitis Optica Spectrum Disorder. Pathogenic Differences With Occasional Clinical and Neuroimaging Overlap. A Review.

    Current neurology and neuroscience reports·2026
    Same journal

    When is the Radiologically Isolated Syndrome already Multiple Sclerosis According to the 2024 McDonald Criteria?

    Current neurology and neuroscience reports·2026
    Same journal

    Assessment and Management of Post-traumatic Headache.

    Current neurology and neuroscience reports·2026
    See all related articles

    Area of Science:

    • Neuroscience
    • Genetics
    • Molecular Biology

    Background:

    • Huntington's disease (HD) is a severe neurodegenerative disorder.
    • It is characterized by motor, cognitive, and behavioral impairments.
    • The genetic basis involves an expanded polyglutamine repeat in the huntingtin gene.

    Purpose of the Study:

    • To review recent advancements in understanding HD pathogenesis.
    • To summarize current therapeutic strategies and future directions for HD treatment.

    Main Methods:

    • Literature review of recent scientific publications on Huntington's disease.
    • Synthesis of findings on molecular and cellular mechanisms.
    • Analysis of progress in therapeutic development.

    Related Experiment Videos

    Main Results:

    • Key pathogenic mechanisms include protein aggregation, transcriptional issues, mitochondrial dysfunction, excitotoxicity, and impaired cellular transport.
    • Despite limited current options, targeted therapies for HD show promise.

    Conclusions:

    • Understanding HD pathogenesis is advancing rapidly.
    • New therapeutic avenues offer hope for managing Huntington's disease.